AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
COMPARISON OF PATIENT AND PROXY EORTC QLQ-C30 RATINGS IN ASSESSING THE QUALITY-OF-LIFE OF CANCER-PATIENTS
Authors: SNEEUW KCA AARONSON NK SPRANGERS MAG DETMAR SB WEVER LDV SCHORNAGEL JH
Citation: Kca. Sneeuw et al., COMPARISON OF PATIENT AND PROXY EORTC QLQ-C30 RATINGS IN ASSESSING THE QUALITY-OF-LIFE OF CANCER-PATIENTS, Journal of clinical epidemiology, 51(7), 1998, pp. 617-631
RANDOMIZED TRIAL OF HIGH-DOSE CHEMOTHERAPY AND HEMATOPOIETIC PROGENITOR-CELL SUPPORT IN OPERABLE BREAST-CANCER WITH EXTENSIVE AXILLARY LYMPH-NODE INVOLVEMENT
Authors: RODENHUIS S RICHEL DJ VANDERWALL E SCHORNAGEL JH BAARS JW KONING CCE PETERSE JL BORGER JH NOOIJEN WJ BAKX R DALESIO O RUTGERS E
Citation: S. Rodenhuis et al., RANDOMIZED TRIAL OF HIGH-DOSE CHEMOTHERAPY AND HEMATOPOIETIC PROGENITOR-CELL SUPPORT IN OPERABLE BREAST-CANCER WITH EXTENSIVE AXILLARY LYMPH-NODE INVOLVEMENT, Lancet, 352(9127), 1998, pp. 515-521
A STRUCTURALLY ALTERED HUMAN REDUCED FOLATE CARRIER WITH INCREASED FOLIC-ACID TRANSPORT MEDIATES A NOVEL MECHANISM OF ANTIFOLATE RESISTANCE
Authors: JANSEN G MAURITZ R DRORI S SPRECHER H KATHMANN I BUNNI M PRIEST DG NOORDHUIS P SCHORNAGEL JH PINEDO HM PETERS GJ ASSARAF YG
Citation: G. Jansen et al., A STRUCTURALLY ALTERED HUMAN REDUCED FOLATE CARRIER WITH INCREASED FOLIC-ACID TRANSPORT MEDIATES A NOVEL MECHANISM OF ANTIFOLATE RESISTANCE, The Journal of biological chemistry, 273(46), 1998, pp. 30189-30198
THE FORMATION AND REPAIR OF CISPLATIN-DNA ADDUCTS IN WILD-TYPE AND CISPLATIN-RESISTANT L1210 CELLS - COMPARISON OF IMMUNOCYTOCHEMICAL DETERMINATION WITH DETECTION IN ISOLATED DNA
Authors: BLOMMAERT FA FLOOT BGJ VANDIJKKNIJNENBURG HCM BERENDS F BAAN RA SCHORNAGEL JH DENENGELSE L FICHTINGERSCHEPMAN AMJ
Citation: Fa. Blommaert et al., THE FORMATION AND REPAIR OF CISPLATIN-DNA ADDUCTS IN WILD-TYPE AND CISPLATIN-RESISTANT L1210 CELLS - COMPARISON OF IMMUNOCYTOCHEMICAL DETERMINATION WITH DETECTION IN ISOLATED DNA, Chemico-biological interactions, 108(3), 1998, pp. 209-225
THE USE OF HEALTH-RELATED QUALITY-OF-LIFE MEASURES IN DAILY CLINICAL-PRACTICE
Authors: DETMAR SB AARONSON NK WEVER LDV VANTUIJL C MULLER MJ SCHORNAGEL JH
Citation: Sb. Detmar et al., THE USE OF HEALTH-RELATED QUALITY-OF-LIFE MEASURES IN DAILY CLINICAL-PRACTICE, Quality of life research, 6(7-8), 1997, pp. 78-78
THE DISCUSSION OF QUALITY-OF-LIFE ISSUES DURING OUTPATIENT CANCER CONSULTATIONS
Authors: DETMAR SB AARONSON NK WEVER LDV VANTUIJL C MULLER MJ SCHORNAGEL JH
Citation: Sb. Detmar et al., THE DISCUSSION OF QUALITY-OF-LIFE ISSUES DURING OUTPATIENT CANCER CONSULTATIONS, Quality of life research, 6(7-8), 1997, pp. 79-79
COMPARISON OF PATIENT AND PROXY EORTC QLQ-C30 RATINGS IN ASSESSING THE QUALITY-OF-LIFE OF CANCER-PATIENTS
Authors: SNEEUW KCA AARONSON NK DETMAR SB WEVER DV SPRANGERS MAG SCHORNAGEL JH
Citation: Kca. Sneeuw et al., COMPARISON OF PATIENT AND PROXY EORTC QLQ-C30 RATINGS IN ASSESSING THE QUALITY-OF-LIFE OF CANCER-PATIENTS, Quality of life research, 6(7-8), 1997, pp. 363-363
THE VALUE OF CAREGIVER COOP WONCA CHART RATINGS IN EVALUATING THE QUALITY-OF-LIFE OF PATIENTS WITH CANCER/
Authors: SNEEUW KCA AARONSON NK DETMAR SB WEVER LDV SPRANGERS MAG SCHORNAGEL JH
Citation: Kca. Sneeuw et al., THE VALUE OF CAREGIVER COOP WONCA CHART RATINGS IN EVALUATING THE QUALITY-OF-LIFE OF PATIENTS WITH CANCER/, Quality of life research, 6(7-8), 1997, pp. 364-364
A RANDOMIZED SINGLE-INSTITUTION STUDY OF HIGH-DOSE CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, THIOTEPA AND CARBOPLATIN (CTC) IN APICAL NODE-POSITIVE BREAST-CANCER
Authors: RODENHUIS S RICHEL DJ BAARS JW SCHORNAGEL JH BORGER JH KONING C RUTGERS E
Citation: S. Rodenhuis et al., A RANDOMIZED SINGLE-INSTITUTION STUDY OF HIGH-DOSE CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, THIOTEPA AND CARBOPLATIN (CTC) IN APICAL NODE-POSITIVE BREAST-CANCER, European journal of cancer, 33, 1997, pp. 977-977
A PHASE-I STUDY WITH S-1, AN ORAL 5-FU FORMULATION, IN PATIENTS WITH SOLID TUMORS
Authors: VANGROENINGEN CJ SCHORNAGEL JH PETERS GJ NOORDHUIS P VANKUILENBURG ABP SHIRASAKA T SHIMAMURA Y DEVRIES MJ HANAUSKE AR
Citation: Cj. Vangroeningen et al., A PHASE-I STUDY WITH S-1, AN ORAL 5-FU FORMULATION, IN PATIENTS WITH SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1104-1104
VALUE OF CAREGIVER RATINGS IN EVALUATING THE QUALITY-OF-LIFE OF PATIENTS WITH CANCER
Authors: SNEEUW KCA AARONSON NK SPRANGERS MAG DETMAR SB WEVER LDV SCHORNAGEL JH
Citation: Kca. Sneeuw et al., VALUE OF CAREGIVER RATINGS IN EVALUATING THE QUALITY-OF-LIFE OF PATIENTS WITH CANCER, Journal of clinical oncology, 15(3), 1997, pp. 1206-1217
HYPERSENSITIVITY REACTIONS TO ETOPOSIDE
Authors: HOETELMANS RWM SCHORNAGEL JH HUININK WWT BEIJNEN JH
Citation: Rwm. Hoetelmans et al., HYPERSENSITIVITY REACTIONS TO ETOPOSIDE, The Annals of pharmacotherapy, 30(4), 1996, pp. 367-371
THE TOXICITY OF RADIOTHERAPY FOLLOWING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN HIGH-RISK BREAST-CANCER - A PRELIMINARY-ANALYSIS
Authors: VANDERWALL E SCHAAKEKONING CCE VANZANDWIJK N BAARS JW SCHORNAGEL JH RICHEL DJ RUTGERS EJT BORGER JH BEIJNEN JH RODENHUIS S
Citation: E. Vanderwall et al., THE TOXICITY OF RADIOTHERAPY FOLLOWING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN HIGH-RISK BREAST-CANCER - A PRELIMINARY-ANALYSIS, European journal of cancer, 32A(9), 1996, pp. 1490-1497
FEASIBILITY OF MULTIPLE COURSES OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN FOR BREAST-CANCER OR GERM-CELL CANCER
Authors: RODENHUIS S WESTERMANN A HOLTKAMP MJ NOOIJEN WJ BAARS JW VANDERWALL E SLAPERCORTENBACH ICM SCHORNAGEL JH
Citation: S. Rodenhuis et al., FEASIBILITY OF MULTIPLE COURSES OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN FOR BREAST-CANCER OR GERM-CELL CANCER, Journal of clinical oncology, 14(5), 1996, pp. 1473-1483
SCHEDULE-DEPENDENT EDATREXATE TOXICITY - REPLY
Authors: SCHORNAGEL JH
Citation: Jh. Schornagel, SCHEDULE-DEPENDENT EDATREXATE TOXICITY - REPLY, Journal of clinical oncology, 14(1), 1996, pp. 322-323
THE FORMATION AND PERSISTENCE OF CARBOPLATIN-DNA ADDUCTS IN RATS
Authors: BLOMMAERT FA MICHAEL C VANDIJKKNIJNENBURG HCM SCHORNAGEL JH DENENGELSE L FICHTINGERSCHEPMAN AMJ
Citation: Fa. Blommaert et al., THE FORMATION AND PERSISTENCE OF CARBOPLATIN-DNA ADDUCTS IN RATS, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 273-280
FUNCTIONAL-ASPECTS OF MEMBRANE FOLATE RECEPTORS IN HUMAN BREAST-CANCER CELLS WITH TRANSPORT RELATED RESISTANCE TO METHOTREXATE
Authors: PINARD MF JOLIVET J RATNAM M KATHMANN I MOLTHOFF C WESTERHOF R SCHORNAGEL JH JANSEN G
Citation: Mf. Pinard et al., FUNCTIONAL-ASPECTS OF MEMBRANE FOLATE RECEPTORS IN HUMAN BREAST-CANCER CELLS WITH TRANSPORT RELATED RESISTANCE TO METHOTREXATE, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 281-288
MOBILIZATION OF BLOOD PROGENITOR CELLS WITH IFOSFAMIDE AND ETOPOSIDE (VP-16) IN COMBINATION WITH RECOMBINANT HUMAN G-CSF (FILGRASTIM) IN PATIENTS WITH MALIGNANT-LYMPHOMAS OR SOLID TUMORS
Authors: BAARS JW HOLTKAMP MJ NOOYEN WJ WALLL EVD VELDE AT DALESIO O SLAPERCORTENBACH ICM SCHOOT EVD RICHEL DJ GERRITSEN WR SCHORNAGEL JH RODENHUIS S
Citation: Jw. Baars et al., MOBILIZATION OF BLOOD PROGENITOR CELLS WITH IFOSFAMIDE AND ETOPOSIDE (VP-16) IN COMBINATION WITH RECOMBINANT HUMAN G-CSF (FILGRASTIM) IN PATIENTS WITH MALIGNANT-LYMPHOMAS OR SOLID TUMORS, Anticancer research, 16(5B), 1996, pp. 3089-3095
ENDOCYTOSIS OF GPI-LINKED MEMBRANE FOLATE RECEPTOR-ALPHA
Authors: RIJNBOUTT S JANSEN G POSTHUMA G HYNES JB SCHORNAGEL JH STROUS GJ
Citation: S. Rijnboutt et al., ENDOCYTOSIS OF GPI-LINKED MEMBRANE FOLATE RECEPTOR-ALPHA, The Journal of cell biology, 132(1-2), 1996, pp. 35-47
EFFICACY OF UP-FRONT 5-FLUOROURACIL-EPIDOXORUBICIN-CYCLOPHOSPHAMIDE (FEC) CHEMOTHERAPY WITH AN INCREASED DOSE OF EPIDOXORUBICIN IN HIGH-RISK BREAST-CANCER PATIENTS
Authors: VANDERWALL E RUTGERS EJT HOLTKAMP MJ BAARS JW SCHORNAGEL JH PETERSE JL BEIJNEN JH RODENHUIS S
Citation: E. Vanderwall et al., EFFICACY OF UP-FRONT 5-FLUOROURACIL-EPIDOXORUBICIN-CYCLOPHOSPHAMIDE (FEC) CHEMOTHERAPY WITH AN INCREASED DOSE OF EPIDOXORUBICIN IN HIGH-RISK BREAST-CANCER PATIENTS, British Journal of Cancer, 73(9), 1996, pp. 1080-1085
MULTIPLE COURSES OF HIGH-DOSE ALKYLATING THERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT
Authors: RODENHUIS S VANDERWALL E SCHORNAGEL JH HOLTKAMP M NOOIJEN WJ BAARS JW
Citation: S. Rodenhuis et al., MULTIPLE COURSES OF HIGH-DOSE ALKYLATING THERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT, European journal of cancer, 31A, 1995, pp. 12-12
PHASE-I AND PHARMACOKINETIC STUDY OF TOPOTECAN (T) IN COMBINATION WITH ORAL ETOPOSIDE (E)
Authors: HERBEN VMM HUININK WWT RODENHUIS S SCHORNAGEL JH BEIJNEN JH
Citation: Vmm. Herben et al., PHASE-I AND PHARMACOKINETIC STUDY OF TOPOTECAN (T) IN COMBINATION WITH ORAL ETOPOSIDE (E), European journal of cancer, 31A, 1995, pp. 940-940
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
AN EORTC PILOT-STUDY OF FILGRASTIM (RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) AS SUPPORT TO A HIGH DOSE-INTENSIVE EPIADRIAMYCIN-CYCLOPHOSPHAMIDE REGIMEN IN CHEMOTHERAPY-NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST-CANCER
Authors: PICCART MJ BRUNING P WILDIERS J AWADA A SCHORNAGEL JH THOMAS J TOMIAK E BARTHOLOMEUS S WITTEVEEN PO PARIDAENS R
Citation: Mj. Piccart et al., AN EORTC PILOT-STUDY OF FILGRASTIM (RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) AS SUPPORT TO A HIGH DOSE-INTENSIVE EPIADRIAMYCIN-CYCLOPHOSPHAMIDE REGIMEN IN CHEMOTHERAPY-NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST-CANCER, Annals of oncology, 6(7), 1995, pp. 673-677
PILOT-STUDY OF A HIGH-DOSE CARBOPLATIN-BASED SALVAGE STRATEGY FOR RELAPSING OR REFRACTORY GERM-CELL CANCER
Authors: RODENHUIS S VANDERWALL E HUININK WWT SCHORNAGEL JH RICHEL DJ VLASVELD LT
Citation: S. Rodenhuis et al., PILOT-STUDY OF A HIGH-DOSE CARBOPLATIN-BASED SALVAGE STRATEGY FOR RELAPSING OR REFRACTORY GERM-CELL CANCER, Cancer investigation, 13(4), 1995, pp. 355-362
Risultati: 1-25 | 26-40